Chaoju Eye Care (02219) Releases Next Day Disclosure Return

Bulletin Express11-20

Chaoju Eye Care (02219) announced that as of 20 November 2025, its total number of issued ordinary shares remained at 707,510,500. The report shows that share repurchases were conducted on 19 and 20 November 2025, each involving 120,000 shares for cancellation. The respective average repurchase prices were HKD 2.5651 on 19 November and HKD 2.5881 on 20 November.

According to the filing, the company’s share repurchase mandate was granted on 06 June 2025, authorizing up to 70,751,050 shares for repurchase. So far, 240,000 shares have been repurchased in total, representing approximately 0.034% of the issued shares as of the date of the mandate. A 30-day moratorium period after these repurchases ends on 20 December 2025, during which no new shares will be issued or transferred without prior approval from the Exchange.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment